IRIS
MAPELLI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.812
NA - Nord America 1.774
EU - Europa 1.178
SA - Sud America 453
AF - Africa 34
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.688
SG - Singapore 714
CN - Cina 574
BR - Brasile 366
IT - Italia 284
SE - Svezia 265
HK - Hong Kong 235
DE - Germania 143
VN - Vietnam 137
ES - Italia 101
FI - Finlandia 93
RU - Federazione Russa 86
GB - Regno Unito 55
CA - Canada 52
AR - Argentina 37
IN - India 35
PL - Polonia 32
FR - Francia 31
MX - Messico 28
IE - Irlanda 22
BD - Bangladesh 20
AU - Australia 19
ID - Indonesia 19
NL - Olanda 18
AT - Austria 17
TR - Turchia 17
EC - Ecuador 16
JP - Giappone 16
ZA - Sudafrica 16
PY - Paraguay 9
CL - Cile 7
IQ - Iraq 7
LT - Lituania 7
MA - Marocco 7
PE - Perù 7
CO - Colombia 6
PT - Portogallo 6
UA - Ucraina 6
IL - Israele 5
MY - Malesia 5
BE - Belgio 4
IR - Iran 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
KE - Kenya 3
PK - Pakistan 3
TW - Taiwan 3
BG - Bulgaria 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
JO - Giordania 2
NP - Nepal 2
UY - Uruguay 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
BO - Bolivia 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GT - Guatemala 1
KR - Corea 1
KZ - Kazakistan 1
LV - Lettonia 1
MR - Mauritania 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PW - Palau 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TN - Tunisia 1
Totale 5.275
Salva come PNG Salva come JPEG
Città #
Dallas 578
Singapore 350
Hong Kong 235
Ashburn 206
Shanghai 140
Milan 138
Beijing 115
New York 102
Hefei 92
Valencia 86
Munich 75
Lawrence 63
Princeton 63
Ho Chi Minh City 52
Turku 50
Boardman 45
Los Angeles 43
Helsinki 37
Moscow 36
São Paulo 34
Hanoi 33
Dublin 22
Montreal 22
Warsaw 22
Santa Clara 21
Brooklyn 20
Rome 19
London 18
Stockholm 15
Atlanta 14
The Dalles 14
Toronto 14
Columbus 13
Poplar 13
Seattle 13
Ankara 12
Frankfurt am Main 12
Orem 12
Tokyo 12
Denver 11
Johannesburg 11
Phoenix 11
Washington 11
Chennai 10
Mexico City 10
Chicago 9
Falkenstein 9
Guangzhou 9
Rio de Janeiro 9
Amsterdam 8
Bexley 8
Da Nang 8
Houston 8
Nuremberg 8
San Francisco 8
West Jordan 8
Haiphong 7
New Delhi 7
Quito 7
Belo Horizonte 6
Boston 6
Canberra 6
Fortaleza 6
Lappeenranta 6
Lima 6
Mumbai 6
Philadelphia 6
Vienna 6
Adelaide 5
Brasília 5
Curitiba 5
Guarulhos 5
Guayaquil 5
Hamilton 5
Itaquaquecetuba 5
Lublin 5
Manchester 5
Naples 5
Pessano Con Bornago 5
Querétaro 5
Secaucus 5
Shenzhen 5
Sydney 5
São João da Madeira 5
Aracaju 4
Bauru 4
Brussels 4
Buffalo 4
Calgary 4
Can Tho 4
Dhaka 4
Foshan 4
Hangzhou 4
Kuala Lumpur 4
Montecchio Maggiore 4
Pesaro 4
Romagnano Sesia 4
Surabaya 4
São Bernardo do Campo 4
Tashkent 4
Totale 3.236
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 130
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 124
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 120
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 119
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 117
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 111
Data-Driven Motion Correction of 11C-Methionine PET Images on a Cohort of Pediatric Patients With Brain Tumor in a PET/MRI Study 108
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 107
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 107
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 97
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 96
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 95
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 92
Hypoxia pathway: 18F-FAZA 90
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 88
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 87
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 86
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 86
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 85
11C-or18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer 80
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 79
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 79
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 79
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 75
Clinical implication of multimodality imaging of aortic root intramural hematoma 74
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 73
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 73
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 73
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 72
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 72
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 71
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 69
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 69
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 67
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 65
Radiomics and artificial intelligence 63
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 63
[Multi-modality imaging: mycotic abscess of a pericardial patch]. FT Imaging multimodale: ascesso micotico su patch di pericardio 63
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 61
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 60
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT 58
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 57
Nuclear medicine in prostate cancer management 57
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 56
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 56
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 53
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 53
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 52
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 50
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas 50
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 49
Association of IgG4-related disease and systemic rheumatic disorders 48
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 48
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 47
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 47
PET/MRI and prostate cancer 45
Imaging in evaluation of response to neo-adjuvant treatment 43
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 42
Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis 42
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 41
PET imaging for lymph node dissection in prostate cancer 40
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 40
The role of positron emission tomography/computed tomography (Pet/ct) for staging and disease response assessment in localized and locally advanced pancreatic cancer 40
Hypoxia18F-FAZA PET/CT imaging in lung cancer and high-grade glioma: open issues in clinical application 38
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 38
Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia 37
The relationship between local recurrences and distant metastases in prostate cancer: can11C-choline PET/CT contribute to understand the link? 37
Pancreatic metastases from primary ileal NET only detected by 68Ga-DOTATOC PET/CT 37
Evaluation of prostate cancer with11C-Choline PET/CT for treatment planning, response assessment, and prognosis 35
Clinical PET imaging of tumour hypoxia in lung cancer 35
PET/MRI in Neuroendocrine Tumours: Blessings and Curses 35
DETECTION OF BONE METASTASES AND EVALUATION OF THERAPY RESPONSE IN PROSTATE CANCER PATIENTS BY RADIOLABELLED CHOLINE PET/CT 34
Incidental Finding of Parathyroid Adenoma With C-11-Choline PET/CT 34
Lymph nodal metastases: diagnosis and treatment 33
POSITRON EMISSION TOMOGRAPHY/MAGNETIC RESONANCE IMAGING 32
Sarcoidosis mimicking metastatic gynaecological malignancies: A diagnostic and therapeutic challenge? 32
Initial prostate cancer diagnosis and disease staging - The role of choline-PET-CT 30
Optical imaging in lung cancer—follow the light, towards molecular imaging–guided precision surgery 30
PET/MRI 29
Imaging biomarkers in prostate cancer: role of PET/CT and MRI 29
Detection of bone metastases and evaluation of therapy response in prostate cancer patients by radiolabelled choline PET/CT 28
Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer 28
PET guidance in prostate cancer radiotherapy: Quantitative imaging to predict response and guide treatment 28
TECNICHE, METODOLOGIE, APPLICAZIONI DIAGNOSTICA PER IMMAGINI 28
Reply to the letter "Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients" 27
FDG-PET/CT predicts outcome in oropharingeal carcinoma patients undergoing intensity modulated radiation therapy with dose escalation to FDG-avid tumour volumes 27
PET/MRI in gynecological tumors 26
Imaging biomarkers in ovarian cancer: the role of ¹⁸F-FDG PET/CT 26
Prostate cancer recurrence: can PSA guide imaging? 26
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on F-18-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 25
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL 25
Erdheim-Chester Disease Imaging-Guided Therapeutic Approach 24
Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by F-18-FDG PET/CT 22
High-grade endometrial cancer: value of [F-18]FDG PET/CT in preoperative staging 21
Diagnostic Accuracy of Fully Hybrid PET/MRI with [ 68 Ga]Ga-PSMA-11 and [ 68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard 2
The relationship between gleason score and 11c-choline pet/ct positive detection rate in prostate cancer patients with biochemical failure after radical prostatectomy: biological and methodological factors 1
Totale 5.478
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.228
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 2 0 0 0 0 0 0
2021/2022106 0 6 0 31 11 5 9 11 14 11 2 6
2022/2023526 145 95 42 30 20 49 39 52 9 22 3 20
2023/2024604 44 27 109 64 40 91 22 56 9 20 33 89
2024/20251.475 144 33 43 41 88 113 264 140 173 145 122 169
2025/20262.697 392 378 725 710 447 45 0 0 0 0 0 0
Totale 5.478